GeoVax Reports 2021 Year-End Financial Results and Provides

Advancing Phase 2 Clinical Trials for COVID-19 and Immuno-Oncology  ATLANTA, GA, March 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax...

Related Keywords

, National Cancer Institute , Emory University , Drug Administration , Nasdaq , Geovax Labs Inc , Therapeutics Inc , Products Clinical Trials Grants Program , Stanford University , Advancing Phase , Geovax Labs , Standard Time , Trials Underway , Immunocompromised Patients , Booster Vaccine , Enabling Activities Progressing , Japan Coronavirus Vaccine , Trial Underway , Advanced Head , Gene Directed Enzyme Prodrug Therapy , Orphan Products Clinical Trials Grants , Nasdaq Govx , Geovax , Nc ,